ASX : EMDInvestor update for the full year ended 30 June 2026September 2026Investor WebinarDisclaimerThis presentation has been prepared by Emyria Limited ACN 625 085 734 (Company or Emyria). This presentation is not a financial product or investment advice or recommendation, offer or invitation by...
Emyria Year End Presentation for Investor Webinar
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Emyria
- Emyria Financial Year-end Update Webinar
- Revised Securities Trading Policy
- Appendix 4E & Annual Financial Report Year End 30 June 2026
- 2026 Annual General Meeting - Key Dates
- Emyria Unlocks Treatment Capacity
Later from Emyria
- Emyria Set to Launch First NSW Clinic
- FDA Selects EMD to Present at Psychedelic Medicines Hearing
- Emyria Presentation at FDA Hearing
- Former US Veterans Affairs Secretary Joins Emyria
- Application for quotation of securities - EMD
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria